EF5 in Melanoma Patients
NCT01752257
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Melanoma
Interventions
DRUG:
EF5 Hypoxia
Sponsor
Douglas Tyler
Collaborators
[object Object]